Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/29807
Title: Oxysterols selectively promote short-term apoptosis in tumor cell lines
Authors: LEVY, DeboraMELO, Thatiana Correa deOHIRA, Bianca YumiFIDELIS, Maira LuisaRUIZ, Jorge L. M.RODRIGUES, AlessandroBYDLOWSKI, Sergio P.
Citation: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, v.505, n.4, p.1043-1049, 2018
Abstract: Oxysterols are 27-carbon oxidation products of cholesterol metabolism. Oxysterols possess several biological actions, including the promotion of cell death. Here, we examined the ability of several oxysterols to induce short-term death in cancerous (human breast cancer and mouse skin melanoma cells) and non-cancerous (human endothelial cells and lung fibroblasts) cell lines. We determined cell viability, Ki67 expression, cell cycle regulation, and apoptosis after 24-h incubations with oxysterols. We found that different oxysterols had different effects on the studied parameters. Moreover, the effects depended on cell type and oxysterol concentration. Three cytotoxic oxysterols (7-ketocholesterol, cholestane-3 beta-5 alpha-6 beta-triol, and 5 alpha-cholestane-3 beta,6 beta-diol) inhibited the S phase and stimulated the G0/G1 or G2/M phases. These oxysterols promoted apoptosis, determined with Annexin V and propidium iodide assays. These results showed that different oxysterols have cytotoxic effects depending on the cell line. The findings suggest a potential pharmacological utility of cytotoxic oxysterols.
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCM
Departamento de Clínica Médica - FM/MCM

Artigos e Materiais de Revistas Científicas - LIM/31
LIM/31 - Laboratório de Genética e Hematologia Molecular


Files in This Item:
File Description SizeFormat 
art_LEVY_Oxysterols_selectively_promote_shortterm_apoptosis_in_tumor_cell_2018.PDF
  Restricted Access
publishedVersion (English)1.14 MBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.